Physician profile
Judd D Hunter
NPI 1831428705
$31,569.65
in general payments reported to CMS, 2019-2025
50 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $968 · 2022: $3,000 · 2023: $2,360 · 2024: $5,976 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $13K · Food and Beverage: $8,212 · Travel and Lodging: $3,894 · Consulting Fee: $1,463 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $975 · Education: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $12,800.00 |
| Food and Beverage | $8,212.27 |
| Travel and Lodging | $3,894.38 |
| Consulting Fee | $1,462.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $975.00 |
| Education | $256.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $18,995.59 | 2022-2025 | Sunosi |
| Inspire Medical Systems, INC. | $4,751.89 | 2022-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $1,831.38 | 2021-2025 | |
| Harmony Biosciences LLC | $933.17 | 2021-2025 | Wakix |
| Abbvie INC. | $598.66 | 2021-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $511.97 | 2023-2025 | Lumryz |
| Novo Nordisk INC | $344.60 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $311.93 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $276.05 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Amgen INC. | $259.41 | 2021-2025 | Evenity, Prolia, Repatha |
| Astellas Pharma US INC | $214.75 | 2022-2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.80 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Dexcom, INC. | $168.92 | 2021-2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $157.20 | 2024-2025 | Shingrix, Arexvy |
| Philips North America LLC | $135.55 | 2022-2025 | Patient Interface Software, (Di7) Home Pi Undivided, (6299) Dreamwear |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $129.18 | 2021-2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $118.77 | 2023-2024 | Quviviq |
| Novartis Pharmaceuticals Corporation | $118.53 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $101.96 | 2022 | |
| Resmed Corp | $97.75 | 2021-2024 | |
| Pfizer INC. | $91.16 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $89.36 | 2022-2025 | Verquvo, Steglatro, Belsomra |
| E.R. Squibb & Sons, L.L.C. | $83.67 | 2021-2023 | Eliquis |
| Actelion Pharmaceuticals US, INC. | $83.22 | 2023-2024 | Opsumit, Uptravi, Acclarent Aera |
| Fisher & Paykel Healthcare INC | $79.78 | 2022-2025 | Fisher & Paykel Healthcare |
| Daiichi Sankyo INC. | $77.32 | 2021-2025 | Injectafer |
| Exeltis, USA INC. | $67.34 | 2025 | Slynd, Twirla |
| Sumitomo Pharma America, INC. | $55.17 | 2023 | Gemtesa |
| Sanofi-Aventis U.S. LLC | $54.64 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.94 | 2024 | |
| Antares Pharma, INC. | $52.99 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $52.25 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $50.48 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $41.52 | 2024-2025 | Voquezna |
| Sanofi Pasteur INC. | $39.06 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $38.98 | 2023-2024 | Spravato, Xarelto |
| Neurocrine Biosciences, INC. | $37.73 | 2023-2024 | Ingrezza, Ongentys |
| 3b Medical, INC. | $32.47 | 2025 | Luna |
| Averitas Pharma INC. | $29.99 | 2025 | Qutenza |
| Arbor Pharmaceuticals, INC. | $25.22 | 2021 | |
| Eisai INC. | $22.71 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $20.27 | 2025 | Neffy |
| Biogen, INC. | $18.52 | 2021 | |
| Lundbeck LLC | $17.49 | 2023 | Rexulti |
| Azurity Pharmaceuticals, INC. | $17.08 | 2025 | Horizant |
| Baxter Healthcare | $14.80 | 2023 | Hillrom - Life 2000 Ventilation System |
| Radius Health, INC. | $14.30 | 2024 | Tymlos |
| Amarin Pharma, INC. | $14.30 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.06 | 2024 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judd Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.